A new study shows that modified citrus pectin offers hope and healing for prostate cancer patients.
Search Results for: cancer
Charlie Rice, a Vietnam veteran, says, “It’s not over until it’s over;” and he has lived his life to prove it.
As a young man, he fought for his country and as a firefighter for many years he served his community. His next battle was prostate cancer.
He felt quite rejected by the traditional medical establishment and searched far and wide to take measures to fight his cancer. He changed his lifestyle and his diet, but still his PSA was creeping up.
He was introduced to Dr. Eliaz who found that an old injury in Vietnam was the missing piece that needed to be addressed.
In Vivo Results: Formula Safely Fights Breast Cancer & Metastasis
Growth, invasion, metastasis—these are the aggressive traits that make cancer so deadly. In fact, 90 percent of cancer deaths result from metastasis, not the primary tumor. As an integrative cancer specialist, researcher and product formulator, much of my work targets the metastatic process. A main objective of any cancer treatment program is to prevent this deadly disease progression, or slow it to a halt once it begins. However once cancer spreads, it becomes much more invasive and difficult to treat.
New Breakthrough Study: Modified Citrus Pectin Boosts Chemo’s Power against Ovarian Cancer
Ovarian cancer is one of the deadliest cancers because it’s often detected at a late stage, with higher risk of resistance to frontline chemotherapy drugs such as paclitaxel (commonly sold as Taxol). However, a new preclinical study from the University of Tehran and the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, published in the Asian Pacific Journal of Cancer Prevention showed that Modified Citrus Pectin (MCP) increased the effectiveness of paclitaxel against ovarian cancer cells.
Doxorubicin (Dox) is an effective anti-cancer drug, but it’s also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients; however, researchers may have found an answer through combination therapy. A study published in the journal Cell Biology International has shown that combining Dox with the natural supplement Modified Citrus Pectin (MCP) increases the anti-cancer activity of Dox. This finding bodes well for prostate cancer patients, especially those too weak for normal chemotherapy regimens. Combination therapy may allow for lower doses of Dox with enhanced clinical impact and reduced toxicity.
Researchers at Indiana University and Methodist Research Institute studied an innovative medicinal mushroom formula against breast cancer. The impressive results are found in the December issue of the International Journal of Oncology. Lead investigator Dr. Daniel Sliva says, “The formula inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.” The all-natural, doctor-designed formula is a blend of six potent varieties of medicinal mushrooms grown on immune enhancing and cancer fighting botanicals that work together to provide breast protection and immune support. Dr. Sliva adds, “These cultivation conditions help naturally increase the amount of biologically active components in these medicinal mushrooms.”
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer.
Dr. Jun Yan, lead author, explains, “Our findings clearly demonstrate that MCP possesses anti-prostate cancer properties in both androgen-dependent (hormonal sensitive) and androgen-independent (hormonal resistant) prostate cancer cells. These results strongly suggest that MCP can be a promising chemopreventive and therapeutic agent against this malignancy.”
Mammograms get all the attention when it comes to breast cancer detection. And there is good reason for that, as research supports its diagnostic benefits. There are a few additional tests, however, that may help Read More »
Prostate cancer is the second most common cancer in men after skin cancer. Estimates are that 1 in 8 men will be diagnosed with it during their lifetime. And according to the American Cancer Society, Read More »
It’s estimated that close to 250,000 men will be diagnosed with prostate cancer this year in the US. In fact, prostate cancer is the most common cancer in men, aside from non-melanoma skin cancer. In fact, prostate cancer and prostate Read More »
We often refer to cancer as one disease—but it’s not. Cancer manifests very differently depending on where it originates in the body, the person’s overall health condition, and numerous other individual factors. Despite these variations however, research Read More »